Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1074

3'-sialyllactose sodium salt

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants at a level up to 0.28 g/L, as consumed, and in other food categories at the maximum levels specified.
Basis: Scientific procedures
Notifier: Inbiose N.V.
Notifier Address: Technologiepark Zwijnaarde 82 bus 41
B-9052 Gent
Belgium
GRAS Notice (releasable information): GRN 1074 with amendments (in PDF) (7 MB)
Date of closure: Apr 5, 2023
FDA's Letter: FDA has no Questions (in PDF) (383 kB)
-
-